Sector: MedicalNovo Nordisk A/S (NYSE: NVO)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 153 |
Technical : | 118 |
Performance : | 186 |
Overall: | 164 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 156 |
Technical : | 61 |
Performance : | 180 |
Overall: | 121 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 149 |
Technical : | 43 |
Performance : | 205 |
Overall: | 117 |
Number of Stocks: | 306 |
Headlines
- Novo Nordisk - Transaction in Own Shares
Nov 16, 2009 08:47 AM | NVO
- Torrent inaugurates insulin vial manufacturing unit in Gujarat
Nov 14, 2009 01:25 PM | NVO
- South Africa's Table Mountain lights up to mark diabetes day
Nov 14, 2009 06:51 AM | NVO
- Celebrate Canada's Commitment to Cure Diabetes
Nov 13, 2009 06:56 AM | NVO, SNY
- Pharmaceutical Employer Market Strategies: Influencing the Influencers
Nov 12, 2009 07:55 AM | NVO, NVS
- Novo Nordisk A/S: Transaction in Own Shares
Nov 09, 2009 08:12 AM | NVO
- Dividend Capital Total Realty Trust Acquires Office Property in Princeton, NJ
Nov 03, 2009 06:28 PM | NVO
- Are you a Diabetes Champion?
Nov 03, 2009 01:06 PM | NVO, SNY
- Êtes-vous un Champion du Diabète?
Nov 03, 2009 01:06 PM | NVO, SNY
- Novo Nordisk A/S: Director/PDMR Shareholding
Nov 02, 2009 10:19 AM | NVO
- Paladin Reports Record Third Quarter 2009 Financial Results
Nov 11, 2009 07:51 AM | NVO, PFE
- Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families
Aug 27, 2009 09:03 AM | NVO
- Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes
Aug 12, 2009 10:01 AM | NVO
- Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient Option
Aug 10, 2009 09:01 AM | NVO
- Novo Nordisk: Half-Yearly Report
Aug 06, 2009 03:52 AM | NVO, PFE, ZGEN
- Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North America
Aug 05, 2009 08:31 AM | NVO
- Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Jul 27, 2009 11:00 AM | NVO
- Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Jul 25, 2009 09:10 AM | NVO
- NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and Care
Jul 23, 2009 09:03 AM | NVO
- FDA Approves NovoLog(R) Labeling Update
Jul 15, 2009 01:43 PM | NVO
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NVO
|
Compare to S&P
|
| YTD |
27.67 %
|
5.46 %
|
| 4 Weeks |
1.93 %
|
1.39 %
|
| 12 Weeks |
7.24 %
|
0.64 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: 69.81 %
|
|
Sales Growth in Last Quarter: 1.01 %
|
|
Sales Growth in Last Quarter: 5.79 %
|
|
